Welcome to our dedicated page for Ardent Health news (Ticker: ARDT), a resource for investors and traders seeking the latest updates and insights on Ardent Health stock.
Ardent Health, Inc. (NYSE: ARDT) is a healthcare company in the medical care facilities sector that operates 30 acute care hospitals and approximately 280 sites of care across six states. Its news flow provides insight into how the company manages hospital operations, finances and growth initiatives in growing mid-sized urban communities in the United States.
News about Ardent Health frequently centers on its quarterly earnings releases, where the company reports total revenue, net income or net loss attributable to Ardent Health, and non-GAAP measures such as Adjusted EBITDA and Adjusted EBITDAR. These releases also present operating statistics, including admissions, adjusted admissions, inpatient and outpatient surgeries, total surgeries, emergency room visits and net patient service revenue per adjusted admission. Commentary in these reports discusses factors such as demand trends, professional fee expenses, payor denials and accounting estimate changes.
Investors following ARDT news will also see announcements about financial guidance, where Ardent Health provides ranges for full-year total revenue, net income attributable to the company, Adjusted EBITDA, rent expense payable to REITs, diluted earnings per share, adjusted admissions growth, net patient service revenue per adjusted admission growth and capital expenditures. The company’s releases explain that this guidance is based on current plans and expectations and is subject to risks and uncertainties.
Other news items include capital structure updates, such as the amendment and extension of its term loan facility and asset-based lending credit agreement, and the authorization of a $50.0 million stock repurchase program by its board of directors. Ardent Health also issues releases about participation in healthcare and investor conferences, leadership changes and the appointment of executives to roles focused on development and strategic growth.
This ARDT news page aggregates these announcements so readers can review Ardent Health’s earnings reports, guidance updates, financing actions, governance developments and conference participation in one place.
Ardent Health (NYSE: ARDT) reported fourth-quarter and full-year 2025 results on March 4, 2026. 4Q25 revenue was $1.605 billion and adjusted EBITDA was $134 million; full-year 2025 revenue was $6.32 billion and adjusted EBITDA was $545 million. The company ended 2025 with $710 million cash and lease-adjusted net leverage of 2.5x.
Ardent reiterated 2026 guidance: revenue $6.4–6.7 billion, adjusted EBITDA $485–535 million, and expects $55 million of IMPACT program savings in 2026. A conference call is scheduled for March 5, 2026.
Ardent Health (NYSE: ARDT) announced management will participate in investor conferences in March 2026. Presentations include a fireside chat at Leerink on March 9, 2026 at 10:00 a.m. ET in Miami and a virtual fireside chat at KeyBanc with a webcast March 18, 2026 at 2:15 p.m. ET.
A live audio webcast and replays will be available in the Investor Relations section at ir.ardenthealth.com. Management will be available for one-on-one investor meetings for registered attendees; contact details for investor relations were provided.
Ardent Health (NYSE: ARDT) is partnering with hellocare.ai to deploy AI‑assisted virtual physician, nursing, patient observation and safety capabilities across more than 2,000 patient rooms. The rollout standardizes virtual nursing, AI monitoring for fall and pressure‑injury prevention, and aims to extend clinical capacity and operational efficiency.
The platform integrates AI monitoring, purpose‑built hardware and clinical workflows and builds on hellocare.ai’s footprint supporting over 100 health systems.
Ardent Health (NYSE: ARDT) will release fourth quarter and full year 2025 results after market close on Wednesday, March 4, 2026. A conference call and webcast to review results and take questions is scheduled for Thursday, March 5, 2026 at 10:00 a.m. ET.
Investors can access the live webcast and presentation materials in the Investor Relations section at ir.ardenthealth.com. Teleconference dial-in numbers and an access code are provided for live participation and a replay available through March 19, 2026.
Ardent Health (NYSE: ARDT) reported 3Q25 results for the quarter ended September 30, 2025. Total revenue was $1.58 billion (up 8.8% Y/Y; 11.7% ex-$43M accounting estimate change). Adjusted EBITDA rose 46.3% to $143M. The company recorded a $23M net loss vs. $26M net income in 3Q24. Operating cash flow was $154M vs. $90M a year ago. Ardent increased professional liability reserves by $54M related to New Mexico claims and took a $43M revenue reduction from an accounts receivable estimate change. Ardent reaffirmed 2025 revenue guidance and revised 2025 adjusted EBITDA to $530–$555M.
Ardent Health (NYSE: ARDT) will participate in the 2025 Stephens Annual Investment Conference in Nashville on Tuesday, Nov. 18, 2025. Management will take part in a fireside chat on Nov. 18, 2025 at 11:00 a.m. ET.
A live audio webcast and a replay will be available in the Investor Relations section at ir.ardenthealth.com. Management will also be available for one-on-one investor meetings during the conference. For meeting arrangements contact your Stephens sales representative or Dave Styblo at investor.relations@ardenthealth.com.
Ardent Health (NYSE: ARDT) will issue third quarter 2025 results after market close on Wednesday, November 12, 2025. A conference call to review results and host Q&A is scheduled for Thursday, November 13, 2025 at 9:00 a.m. ET. A live webcast and presentation materials will be available in the Investor Relations section at ir.ardenthealth.com. Listeners should access the site at least 15 minutes early to register and install any required audio software.
Teleconference details: North America toll-free 1-888-596-4144, international 1-646-968-2525, access code 4437657. Replay available through November 27, 2025 at North America toll-free 1-800-770-2030 or international 1-647-362-9199 using access code 4437657.
Ardent Health (NYSE: ARDT) has successfully amended and extended its $777.5 million Term Loan Facility. The amendment includes a 50 basis point reduction in the interest rate, from Term SOFR plus 2.75% to Term SOFR plus 2.25%, and extends the maturity to September 2032.
The refinancing is expected to generate annual interest savings of $3.9 million and provides enhanced financial flexibility for the healthcare provider to pursue strategic growth initiatives and community investments.
Ardent Health (NYSE:ARDT), a healthcare provider focused on mid-sized urban communities across the U.S., has announced its participation in three major healthcare investor conferences in September 2025:
- Wells Fargo Healthcare Conference in Boston (September 4, 8:45 a.m. ET)
- Morgan Stanley Global Healthcare Conference in New York City (September 8, 7:45 a.m. ET)
- Jefferies Healthcare Services Conference in Nashville (September 29, 10:45 a.m. ET)
Management will participate in fireside chats at each event, with live webcasts available on the company's investor relations website. One-on-one meetings with registered investors will also be available.
Ardent Health (NYSE:ARDT) reported strong Q2 2025 financial results with notable growth across key metrics. The company achieved total revenue of $1.65 billion, representing an 11.9% year-over-year increase, and net income of $73 million ($0.52 per diluted share).
Key performance highlights include a 38.9% increase in Adjusted EBITDA to $170 million, 6.6% growth in admissions, and 10.2% growth in net patient service revenue per adjusted admission. The company's lease-adjusted net leverage ratio improved to 2.7x from 3.0x in Q1.
Ardent Health reaffirmed its 2025 guidance with projected total revenue of $6.2-6.45 billion and Adjusted EBITDA of $575-615 million. The company continues to expand its ambulatory care network with plans to open five urgent care centers and two imaging care centers before year-end.